Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cost of Revenue: 2010-2013

Historic Cost of Revenue for Tenax Therapeutics (TENX) over the last 2 years, with Apr 2013 value amounting to $352,579.

  • Tenax Therapeutics' Cost of Revenue rose 9594.23% to $352,579 in Q2 2013 from the same period last year, while for Apr 2013 it was $369,158, marking a year-over-year increase of 620.27%. This contributed to the annual value of $129,800 for FY2014, which is 201.08% up from last year.
  • Latest data reveals that Tenax Therapeutics reported Cost of Revenue of $352,579 as of Q2 2013, which was up 22,884.29% from $1,534 recorded in Q1 2013.
  • Tenax Therapeutics' Cost of Revenue's 5-year high stood at $352,579 during Q2 2013, with a 5-year trough of $1,534 in Q1 2013.
  • For the 3-year period, Tenax Therapeutics' Cost of Revenue averaged around $62,885, with its median value being $9,817 (2011).
  • Per our database at Business Quant, Tenax Therapeutics' Cost of Revenue crashed by 98.01% in 2012 and then surged by 9,594.23% in 2013.
  • Quarterly analysis of 4 years shows Tenax Therapeutics' Cost of Revenue stood at $8,957 in 2010, then rose by 17.23% to $10,500 in 2011, then dropped by 13.01% to $9,134 in 2012, then soared by 9,594.23% to $352,579 in 2013.
  • Its last three reported values are $352,579 in Q2 2013, $1,534 for Q1 2013, and $9,134 during Q4 2012.